N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis (NACPSY)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2011 by Beth Israel Deaconess Medical Center
Sponsor:
Collaborator:
Center de Neurosciences Psychiatrique, Lausanne, Switzerland
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01354132
First received: May 13, 2011
Last updated: NA
Last verified: May 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)